Financial Wire

トゥルーイスト社によると、住宅建設会社の収益は戦争の影響と春の販売不振により圧迫される可能性が高い。

-- トゥルーイスト証券は木曜日、中東紛争による経済的影響が既に低迷している春の販売シーズンに重くのしかかり、米国の主要住宅建設会社数社の今年の業績が打撃を受ける可能性が高いと発表した。 同証券は、住宅建設会社6社(D.R.ホートン(DHI)、メリテージ・ホームズ(MTH)、NVR(NVR)、パルテグループ(PHM)、テイラー・モリソン・ホームズ(TMHC)、トール・ブラザーズ(TOL))の次四半期および通期の最終利益予想を引き下げた。 トゥルーイストはまた、2月末に勃発したイラン・イスラエル戦争を主な要因とする原油価格の高騰に伴うインフレと消費者信頼感の低下を考慮し、これら6社の株価目標も引き下げた。 トゥルーイストのアナリスト、ジョナサン・ベッテンハウゼン氏は顧客向けレポートの中で、「この戦争のタイミングは非常に不運だった」と述べている。 「今春の販売シーズンに対する業界の予想は、昨年比で一桁台前半の減少を示唆していたものの、地政学的環境の著しい悪化がこれらの予想に織り込まれていたとは考えにくい」と、同証券会社は述べている。 同証券会社は、担当銘柄の中で「予想を上回る銘柄は多くない」としながらも、最新の四半期決算発表を前に最も注目しているのはテイラー・モリソンだと述べている。ベッテンハウゼン氏は、テイラー・モリソンの株価は「最も悪いニュースが織り込まれている」可能性が高いと指摘している。 「春の販売シーズンに対する楽観的な見方は事実上消滅したと考えており、それに伴い、(上半期)だけでなく、春の(受注生産)新規受注需要の悪化を見込んで、下半期の需要予測も下方修正した」と、同アナリストは述べている。 3月の新築住宅販売件数と新築住宅建設件数のデータはまだ発表されていないが、住宅ローンレポートやGoogleトレンドといった代替市場指標は「需要の好調な動向を示しておらず、これは需要に関する市場の一般的な見方を裏付けるものだ」と、同レポートは述べている。水曜日、全米住宅建設業者協会とウェルズ・ファーゴは、経済の不確実性に加え、建築資材費と金利の上昇を背景に、今月の米国の住宅建設業者の景況感が9月以来の最低水準に落ち込んだと発表した。 ホワイトハウスはイランとの合意に楽観的な見方を示しており、第2回協議はパキスタンで開催される可能性が高いとしている。週末、イスラマバードで行われた米イラン和平交渉は合意に至らずに終了した。一方、ワシントンとテヘランの間では2週間の停戦が継続している。

Price: $144.72, Change: $+0.52, Percent Change: +0.36%

Related Articles

Australia

Sector Update: Financial Stocks Softer Late Afternoon

Financial stocks fell in late Thursday afternoon trading with the NYSE Financial Index and the State Street Financial Select Sector SPDR ETF (XLF) each easing 0.2%.The Philadelphia Housing Index dropped 0.5%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) rose 0.8%.Bitcoin (BTC-USD) gained 0.4% to $75,140, and the yield for 10-year US Treasuries advanced 2.7 basis points to 4.309%.In economic news, US initial jobless claims last week fell to 207,000 from a downwardly revised 218,000 in the previous week, compared with expectations for a smaller decrease to 213,000 in a survey of analysts by Bloomberg.US industrial production fell by 0.5% in March, compared with expectations for a 0.1% increase in a Bloomberg survey, and following an upwardly revised 0.7% increase in February.The Philadelphia Federal Reserve's monthly manufacturing index rose to 26.7 in April after increasing to 18.1 in March, compared with expectations for a decline to 10 in a survey compiled by Bloomberg.The New York Federal Reserve's services index improved to minus 14 in April from minus 22.6 in March, compared with minus 20 expected in a survey compiled by Bloomberg.In regulatory news, the US Securities and Exchange Commission is seeking public comment in support of a comprehensive review of the Consolidated Audit Trail and other such audit trails used in the regulation of the country's securities markets.In corporate news, Charles Schwab's (SCHW) Q1 results rose amid a surge in client assets, even as revenue fell short of Wall Street's estimates. The shares fell 7.7%.Goldman Sachs (GS) rates-trading business faced pressure in Q1 as Iran-related market volatility led to losses on certain positions, Reuters reported. The bank posted a 10% drop in fixed-income, currencies and commodities revenue to $4 billion, driven by weaker results in interest-rate trading, mortgages, and credit products, the report said. Goldman shares were little changed.Marsh & McLennan (MRSH) shares climbed 4.6% after the company reported Q1 adjusted net income and revenue that surpassed analysts' estimates.The National Basketball Association is in early discussions with private credit firms, including Apollo Global Management (APO), Ares Management (ARES) and Sixth Street about funding a potential European basketball league expansion, Bloomberg reported. Apollo shares rose 0.1%, and Ares fell 2.7%.

$APO$ARES$GS$MRSH$SCHW
Japan

US Equity Indexes Advance After Trump Announces Israel-Lebanon Ceasefire Deal

US equity indexes rose ahead of Thursday's close after Israel and Lebanon agreed to a 10-day ceasefire, removing a major obstacle to the Middle East diplomacy for a lasting Iran truce deal.The Nasdaq Composite rose 0.2% to 24,069.1, with the S&P 500 up 0.2% to 7,035.2, and the Dow Jones Industrial Average higher by 0.2% to 48,583.5. Energy, real estate, and technology led the gainers. Health care was the worst performer.President Trump said the US might hold discussions with Iran this weekend, The Wall Street Journal reported. "We're very close to making a deal," the president told reporters outside the White House, according to the WSJ. Trump said he wasn't sure the current two-week ceasefire in the war would need to be extended, according to the report.Earlier on Thursday, Trump said on Truth Social that Lebanon and Israel have agreed to a 10-day ceasefire starting 5 pm ET. Lebanese Prime Minister Nawaf Salam said he welcomed the decision. In a follow-up social media post on Thursday, Trump said he will invite the Lebanese President, Joseph Aoun, and Israel's Prime Minister Benjamin Netanyahu to the White House for talks.Meanwhile, US Defense Secretary Pete Hegseth said Thursday that the naval blockade of Iran is an example of "polite" behavior during the ongoing ceasefire, and US forces are ready to strike power plants and the energy industry in the country, if ordered, according to a report from Reuters.West Texas Intermediate crude oil futures rose 2.5% to $93.77, and Brent crude futures jumped 3.7% to $98.58.

$^DJI$^IXIC$^SPX
Sectors

Sector Update: Health Care Stocks Decline Late Afternoon

Health care stocks were softer late Thursday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each decreasing 0.7%.The iShares Biotechnology ETF (IBB) dropped 1.3%.In corporate news, Abbott Laboratories (ABT) lowered its full-year earnings outlook on Thursday to reflect the acquisition of cancer diagnostics company Exact Sciences, while the healthcare firm reported Q1 results above market estimates. Its shares fell past 5%.Gilead Sciences (GILD) could beat Q1 consensus estimates, but weaker-than-expected persistence rates for Yeztugo point to a potential risk to long-term peak sales for the HIV pre-exposure prophylaxis drug, RBC Capital Markets said in a note. Gilead shares were down 0.8%.QuidelOrtho (QDEL) shares tumbled 28%. The company said late Wednesday it expects preliminary unaudited revenue of $615 million to $620 million for Q1. Analysts polled by FactSet expect $677.8 million.Hims & Hers Health (HIMS) shares jumped past 12% after a senior US health official signaled plans to ease restrictions on certain peptides.

$ABT$GILD$HIMS$QDEL